glp 1 prescribing guidelines How should GLP-1 receptor agonists be managed in the perioperative period? Your GLP-1 medication starter guide

doi: 10.1093/CVR/CVZ323 35 PearsonSKietsirirojeNAjjanRA

Schedule: One subcutaneous injection a week across an 816 week course, with the dose raised in phases

INGREDIENTS L-carnitine L-tartrate (50%), bulking agent (cellulose gel), coating material [stabilisers (polyvinyl alcohol-polyethylene glycol- graft -co-polymer, polyvinyl alcohol), anti-caking agents (talc, mono- and diglycerides of fatty acids), colour (titanium dioxide)], anti-caking agents (magnesium salts of fatty acids, silicon dioxide)

A vitamin B12 test is recommended in order to establish safe and effective administration levels

This review typically takes 6-12 months after Health Canada approval